PharmCAT.NET

Биостатистика, фармакокинетика и клинические исследования.

  • Домашняя страница
    • О сайте
  • Материалы
    • Быстрые команды R Project
    • Ссылки
  • Инструменты
    • Рандомизационный список
  • Блог
    • Статистика
    • Phoenix WinNonlin
    • IT
    • Путевые заметки
  • Контакты
    • Контактные данные
    • Консультации
    • Конфиденциальность
  • Профиль
    • Войти
    • Зарегистрироваться

Julia:ReplicateBE – release 0.2.0

Опубликовано 26 октября, 201926 октября, 2019 frozencat

doiGitHub

Вот и подоспел релиз 0.2.0 для оценки параметров смешанной модели репликативного дизайна биоэквивалентности по методу С (EMA) – FDA model.

 

Рубрики: IT, Julia, Mixed Model, Биоэквивалентность

Навигация по записям

Предыдущая запись: ClinicalTrialUtilities: обзор
Следующая запись: Тест ClinicalTrialUtilities и ReplicateBE на Raspberry Pi 4

Свежие записи

  • Long WS Wide: или про то, как выполнить анализ разницы изменений между группами
  • Частые вопросы: Регистрация и экспертиза по правилам ЕАЭС
  • Главные ошибки при формировании базы данных в MS Excel
  • Тест ClinicalTrialUtilities и ReplicateBE на Raspberry Pi 4
  • Julia:ReplicateBE – release 0.2.0

Галерея

20180131 165349
IMG-20170806-WA0044
DJI 0005
20180813 234759
20170802 183936
20180814 153419
  • Activities Report of the Generic Drug Program | FDARA Title VIII Sections 807 and 805
    Source: FDA - What's New: Drugs RSS Feed Published on 2025-06-10 By FDA
  • Real-World Evidence Submissions to the Center for Drug Evaluation and Research
    Source: FDA - What's New: Drugs RSS Feed Published on 2025-06-10 By FDA
  • Human medicines European public assessment report (EPAR): Rozlytrek, entrectinib, Date of authorisation: 31/07/2020, Revision: 11, Status: Authorised
    Source: EMA - Human medicines: European public assessment reports (EPARs) Published on 2025-06-10
  • Human medicines European public assessment report (EPAR): Rinvoq, upadacitinib, Date of authorisation: 16/12/2019, Revision: 26, Status: Authorised
    Source: EMA - Human medicines: European public assessment reports (EPARs) Published on 2025-06-10
  • ABRYSVO
    Source: FDA - What's New: Vaccines, Blood & Biologics RSS Feed Published on 2025-06-10 By FDA
  • Human medicines European public assessment report (EPAR): Vokanamet, canagliflozin,metformin, Date of authorisation: 23/04/2014, Revision: 25, Status: Authorised
    Source: EMA - Human medicines: European public assessment reports (EPARs) Published on 2025-06-10
  • Human medicines European public assessment report (EPAR): Capvaxive, pneumococcal polysaccharide conjugate vaccine (21-valent), Date of authorisation: 24/03/2025, Revision: 1, Status: Authorised
    Source: EMA - Human medicines: European public assessment reports (EPARs) Published on 2025-06-10
  • Human medicines European public assessment report (EPAR): Zirabev, bevacizumab, Date of authorisation: 14/02/2019, Revision: 15, Status: Authorised
    Source: EMA - Human medicines: European public assessment reports (EPARs) Published on 2025-06-10
  • Human medicines European public assessment report (EPAR): Apexelsin, paclitaxel, Date of authorisation: 24/07/2024, Revision: 2, Status: Authorised
    Source: EMA - Human medicines: European public assessment reports (EPARs) Published on 2025-06-10
  • Sleep, Skin and Bodybuilding Product Notifications
    Source: FDA - What's New: Drugs RSS Feed Published on 2025-06-10 By FDA
  • Sexual Enhancement and Energy Product Notifications
    Source: FDA - What's New: Drugs RSS Feed Published on 2025-06-10 By FDA
  • Amish Origins Management, LLC - 704166 - 05/29/2025
    Source: FDA - What's New: Drugs RSS Feed Published on 2025-06-10 By FDA
  • Sprout Pharmaceuticals, Inc. - 709942 - 05/29/2025
    Source: FDA - What's New: Drugs RSS Feed Published on 2025-06-10 By FDA
  • American Behavioral Research Institute, LLC - 705629 - 04/30/2025
    Source: FDA - What's New: Drugs RSS Feed Published on 2025-06-10 By FDA
  • Bio Wellness 444 LLC - 709333 - 05/30/2025
    Source: FDA - What's New: Drugs RSS Feed Published on 2025-06-10 By FDA
Предыдущие записи
Тема: Scaffold от Danny Cooper.